Literature DB >> 27329504

Quality-of-life aspects in idiopathic epilepsy in dogs.

A Wessmann1, H A Volk2, R M A Packer2, M Ortega3, T J Anderson4.   

Abstract

Quality of life (QoL) plays a significant role in the treatment of dogs with idiopathic epilepsy (IE), yet is so far understudied. This study describes the outcome evaluation of an online questionnaire based on the carer's perception focusing on 62 QoL questions in 159 dogs with IE. Results showed that seizure frequency, but not seizure severity or presence of cluster seizures, was significantly associated with carer-perceived dog's QoL. Dogs receiving third-line antiepileptic drugs had a significantly lower perceived QoL than those that did not. Generalised linear mixed model analysis demonstrated that severity of the side effects sleeping more and ataxia were significantly associated with carer-perceived dog's QoL, with higher severities predicting lower QoL scores. The degree of carer acceptability of seizure frequency and severity was significantly associated with the dog's reported seizure frequency and severity. Moreover, there was a significant association between IE-related QoL changes of the dog and the carer, with reductions in perceived canine QoL scores associated with reductions in carer QoL, and vice versa. In conclusion, aspects of canine IE can affect both the carer and their dog's QoL. This has implications for the management and requires consideration when treatment options and outcomes are discussed. British Veterinary Association.

Entities:  

Keywords:  Dogs; Epilepsy; Human-animal interactions; Neurology

Mesh:

Substances:

Year:  2016        PMID: 27329504     DOI: 10.1136/vr.103355

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  17 in total

1.  Investigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsy.

Authors:  Rowena M A Packer; Luisa De Risio; Holger A Volk
Journal:  BMC Vet Res       Date:  2017-04-07       Impact factor: 2.741

2.  A prospective observational longitudinal study of new-onset seizures and newly diagnosed epilepsy in dogs.

Authors:  N Fredsø; N Toft; A Sabers; M Berendt
Journal:  BMC Vet Res       Date:  2017-02-16       Impact factor: 2.741

3.  Cognitive dysfunction in naturally occurring canine idiopathic epilepsy.

Authors:  Rowena M A Packer; Paul D McGreevy; Hannah E Salvin; Michael J Valenzuela; Chloe M Chaplin; Holger A Volk
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

4.  Grey matter volume in healthy and epileptic beagles using voxel-based morphometry - a pilot study.

Authors:  Lisa Frank; Matthias Lüpke; Draginja Kostic; Wolfgang Löscher; Andrea Tipold
Journal:  BMC Vet Res       Date:  2018-02-20       Impact factor: 2.741

5.  Health-related quality of life in dogs treated with electrochemotherapy and/or interleukin-12 gene electrotransfer.

Authors:  Nina Milevoj; Natasa Tozon; Sabina Licen; Ursa Lampreht Tratar; Gregor Sersa; Maja Cemazar
Journal:  Vet Med Sci       Date:  2020-01-07

6.  Seizure occurrence in dogs under primary veterinary care in the UK: prevalence and risk factors.

Authors:  Alexander Erlen; Heidrun Potschka; Holger A Volk; Carola Sauter-Louis; Dan G O'Neill
Journal:  J Vet Intern Med       Date:  2018-09-14       Impact factor: 3.333

7.  A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol.

Authors:  Benjamin Andreas Berk; Rowena Mary Anne Packer; Tsz Hong Law; Annette Wessmann; Andrea Bathen-Nöthen; Tarja Susanna Jokinen; Anna Knebel; Andrea Tipold; Ludovic Pelligand; Holger Andreas Volk
Journal:  BMC Vet Res       Date:  2019-05-30       Impact factor: 2.741

8.  Behavioral Interventions as an Adjunctive Treatment for Canine Epilepsy: A Missing Part of the Epilepsy Management Toolkit?

Authors:  Rowena M A Packer; Sarah L Hobbs; Emily J Blackwell
Journal:  Front Vet Sci       Date:  2019-01-28

9.  Clinical characteristics, breed differences, and quality of life in North American dogs with acute steroid-responsive meningitis-arteritis.

Authors:  Jeanie Lau; Julie A Nettifee; Peter J Early; Christopher L Mariani; Natasha J Olby; Karen R Muñana
Journal:  J Vet Intern Med       Date:  2019-06-07       Impact factor: 3.333

10.  A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs.

Authors:  Benjamin A Berk; Tsz H Law; Rowena M A Packer; Annette Wessmann; Andrea Bathen-Nöthen; Tarja S Jokinen; Anna Knebel; Andrea Tipold; Ludovic Pelligand; Zoe Meads; Holger A Volk
Journal:  J Vet Intern Med       Date:  2020-04-15       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.